title: [Manganese superoxide dismutase-inhibiting autoantibodies in cholestatic Epstein-Barr viral hepatitis].
abstract: METHODS
  A 21-year-old woman reported no serious previous illness. For 3 days before admission she had a fever, headache and joint pains. She had become progressively more jaundiced. Physical examination was normal except for enlarged liver and spleen, swollen lymph nodes and facial oedema.
  
  
  METHODS
  GOT (30 U/l), GPT (33 U/l) and alkaline phosphatase (172 U/l) were slightly elevated. Serum bilirubin was raised to 12.4 mg/dl. The total white blood cell count was normal, but there were 45% atypical lymphocytes (activated T lymphocytes). Abdominal sonography and endoscopic retrograde cholangiopancreatography were unremarkable. Serology for hepatitis A, B and C as well as for antimitochondrial antibodies was negative, but there were specific IgM (1:640) and IgG antibodies (1:80) against Epstein-Barr virus (EBV) capsid antigen in the immunofluorescence test.
  
  
  METHODS
  The EBV infection (infectious mononucleosis) was complicated by cholestatic hepatitis. High concentrations (1832 Göttingen units/ml) of enzyme-inhibiting autoantibodies against the antioxidative enzyme manganese-superoxide dismutase (MSD) were demonstrated. The autoantibodies reduced the antioxidative action of the enzyme by more than 70% and favoured the oxidative cell damage in vitro. After bed-rest for one week without further treatment the symptoms improved and the abnormal laboratory values, including the autoantibodies against MSD, regressed.
  
  
  CONCLUSIONS
  Autoantibodies against MSD are formed during an acute infection with EBV. Their enzyme-inhibiting action promotes abnormalities of oxidative cell function and may thus be the cause of cholestatic hepatitis in this infection.
authors.affiliation: Lehr- und Forschungsgebiet Virologie, Institut für Medizinische Mikrobiologie, Universitätsklinikum, Rheinisch-Westfälische Technische Hochschule Aachen. schaade@alpha.imib.rwth-aachen.de
authors.forename: L
authors.initials: L
authors.lastname: Schaade
authors.forename: R
authors.initials: R
authors.lastname: Meilicke
authors.forename: S
authors.initials: S
authors.lastname: Büttgen
authors.forename: K
authors.initials: K
authors.lastname: Ritter
mesh_terms: D000328:Adult; D000910:Antibodies, Heterophile / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D001323:Autoantibodies / Q000097:blood*; D002779:Cholestasis / Q000175:diagnosis* / Q000209:etiology; D005260:Female; D006525:Hepatitis, Viral, Human / Q000175:diagnosis* / Q000209:etiology; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007244:Infectious Mononucleosis / Q000150:complications / Q000175:diagnosis*; D013482:Superoxide Dismutase / Q000037:antagonists & inhibitors* / Q000276:immunology*; D013997:Time Factors
chemical_list: D000910:Antibodies, Heterophile; D000914:Antibodies, Viral; D001323:Autoantibodies; D013482:Superoxide Dismutase
vernacular_title: Mangan-Superoxid-Dismutase-hemmende Autoantikörper bei der cholestatischen Epstein-Barr-Virus-Hepatitis.